Non-redundant summary scores applied to the North American Rheumatoid Arthritis Consortium dataset by Pankratz, Nathan D
BMC Proceedings
Proceedings
Non-redundant summary scores applied to the North American
Rheumatoid Arthritis Consortium dataset
Nathan D Pankratz
Address: Department of Medical and Molecular Genetics, Indiana University, School of Medicine, Indianapolis, Indiana 46202, USA
E-mail: npankrat@iupui.edu
from Genetic Analysis Workshop 16
St Louis, MO, USA 17-20 September 2009
Published: 15 December 2009
BMC Proceedings 2009, 3(Suppl 7):S39 doi: 10.1186/1753-6561-3-S7-S39
This article is available from: http://www.biomedcentral.com/1753-6561/3/S7/S39
© 2009 Pankratz; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
After performing a genome-wide association study, it is often difficult to know which regions to
follow up, especially when no one marker reaches genome-wide significance. Researchers
frequently focus on their top N findings, knowing that true associations may be buried deeper in the
list. Others focus on genes or regions that have multiple markers showing evidence of association.
However, these markers are often in high linkage disequilibrium with one another (r
2 >0 . 8 0 ) ,
which indicates that these additional markers are providing redundant information. I propose a
novel method that identifies regions with multiple lines of evidence, by down-weighting the
contribution of additional markers in proportion to pairwise linkage disequilibrium. I have used this
non-redundant summary score in my analysis of the North American Rheumatoid Arthritis
Consortium dataset released as part of Genetic Analysis Workshop 16. Three regions were
identified that had a genome-wide empirical p-value less than 0.01, including one novel region on
chromosome 20 near the KCNB1 and PTGIS genes.
Background
Studies designed to identify genes contributing to
complex diseases have been ongoing for many years,
utilizing different study designs and methods with varied
success. Recently, genome-wide association studies have
become very popular, employing from hundreds of
thousands to millions of single-nucleotide polymorph-
isms (SNPs). When analyzing such datasets, maintaining
an acceptable level of type I error has meant either
employing a Bonferroni correction or an accepted
genome-wide significance threshold that requires a
p-value of around 1 × 10
-8. In many cases this has
proven unattainable, even when genotyping several
thousand samples. Researchers frequently have no
other choice but to list their top findings and hope
that an independent sample (which would not have to
meet such a stringent threshold) can replicate them.
Unfortunately, many of the top hits are indeed false
positives and the true positives have slightly larger
p-values. Finding those true positives might be helped
by focusing on genes or regions that have multiple hits
in them, similar to what is implemented in the computer
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clumping procedure [1]. Unfortunately, due to the
nature of genomic structure, this only provides support
that the genotyping is accurate and does not reflect
independent lines of evidence that the statistical
association is anything more than random chance. Two
SNPs with similar p-values that are in high LD (r
2 =0 . 9 9
or even r
2 > 0.80) are simply providing redundant
information.
This gets at one of the fundamental limitations of
traditional association analyses, namely that it assumes
that there is a single causative variant that was preserved
on a single ancestral haplotype background. In practice,
several variants may lead to the same relevant outcome,
which in this case is usually the up- or down-regulation
of the expression of some gene. The same sequence
change may also have arisen independently on multiple
haplotype backgrounds. Moreover, expression could be
affected by independent variants that are scattered within
the gene, its promoter and its 3’ region, encompassing an
area that can be anywhere from several thousand to over
a million base-pairs. This is an argument for looking at
genes or regions as a whole, while still keeping in mind
that regions close together often exhibit LD. Here I use a
method that generates a score for a region by summariz-
ing all association results within its limits while
weighting each marker’s contribution based on its
pairwise LD to other significant markers.
Methods
Subjects
I have analyzed the Problem 1 dataset that was provided
for Genetic Analysis Workshop 16. This genome-wide
association scan from the North American Rheumatoid
Arthritis Consortium (NARAC) contains data from the
Illumina 550 k chip for 868 cases and 1194 controls. The
discrete trait (presence or absence of rheumatoid
arthritis) is provided along with sex, DRB1 genotype
status, number of shared epitope alleles, and two
quantitative traits (for the cases only). NARAC has
identified several DRB1 alleles that increase the risk for
disease (0101, 0102, 0104, 0105, 0401, 0404, 0405,
0408, 0409, 1001, 1402, and 1406) and has indicated
that a few alleles (0401, 0404, 0405, 0408, and 0409)
increase risk more dramatically that the others.
Quality assessment
Analyses were limited to those markers with a call rate of
95% or higher and a minor allele frequency (MAF) of
0.01 or higher. Fisher’se x a c tt e s tw a se m p l o y e dt oa s s e s s
differential rates of missing genotypes based on disease
classification (case or control), and SNPs with signifi-
cantly different rates of missing genotypes (p < 0.0001)
were removed from further analysis. SNPs demonstrating
significant deviation from Hardy-Weinberg equilibrium
(p < 0.000001) in the control sample were removed from
further analysis. Many markers were flagged for multiple
reasons and a total of 48,739 markers (8.9%) were
removed in this way.
Genome-wide association analyses
Logistic regression was used to generate p-values for each
marker. Sex was not significantly associated with disease
(p = 0.21) and therefore was not included as a covariate
in the model. Number of shared epitope alleles (p =1 . 6×
10
-81) and number of deleterious DRB1 alleles (p =7 . 5×
10
-102) both showed strong evidence of association with
disease and were included as covariates. PLINK was used
to perform these analyses [1]. Pairwise LD was computed
for all markers on a chromosome using the computer
program Haploview [2].
Non-redundant summary scores
Non-redundant summary (NRS) scores were computed
for SNPs that met the threshold to be an index SNP
(p < 0.001). NRS scores were generated as follows: all
adjacent SNPs that were within a certain distance from
the index SNP (150 kb each side) and that met inclusion
criteria (p < 0.01) were flagged. These SNPs were sorted
based on their p-value, and the -log10 of those p-values
was summed sequentially (the one with the lowest
p-value first). As each SNP was added to the score, it was
multiplied by 1 minus the maximum pairwise r
2 value of
any SNP already in the score (i.e., anything more
s i g n i f i c a n t ) .I nt h i sw a y ,r e d u n d a n c yi sm i n i m i z e d .T h e
sum is then divided by the square root of the total
number of SNPs in the region.
Empirical p-values were derived by permuting the
phenotype (covariates and phenotype were linked to
maintain their relationship) and repeating the process
for each replicate. Ten thousand replicates were gener-
ated in this way. Genome-wide significance was deter-
mined by taking the number of replicates generating a
maximum NRS score anywhere in the genome that met
or exceeded the observed score and dividing that number
by the total number of replicates. This algorithm was
implemented using an in-house java application (source
code available upon request).
Results
Association results are summarized in Table 1 and Figure 1.
The strongest evidence of association was obtained to the
regions on chromosome 6 known to be strongly associated
with RA. Association was also noted on chromosomes
9 and 20. All of these regions were statistically significant
(empirical genome-wide p <0 . 0 5 ) .
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Regions with multiple lines of evidence for association -
i.e., association with different LD blocks and with
markers of varying minor allele frequency - can be
effectively summarized using the proposed NRS score.
When applied to the NARAC dataset, three regions were
significantly associated with affection status after adjust-
ing for two covariates and correcting for multiple tests.
The NRS scores for these regions were clearly distinct and
separate from the rest of the distribution. This clear
separation was not nearly as evident when SNPs were
listed individually (pointwise) in a table. In this
application, the SNPs that were individually most
significant were located within the three regions identi-
f i e db yN R S ,a n dn oS N Pt h a tm e tg e n o m e - w i d e
significance individually (p <1 0
-8) was outside of these
three regions. This, however, is not always the case. This
method was recently applied to a study of Parkinson
disease (unpublished data) where no SNP individually
met genome-wide significance. The NRS score, however,
was able to single out a region that was statistically
significant genome-wide.
The regions on chromosome 6, which contains the
human leukocyte antigen (HLA) region and the DRB
alleles, have already been well studied by NARAC. The
other two regions also contain possible candidate genes.
The area on chromosome 9 contains a single gene:
DBC1, which is known for being deleted in breast
cancers and is thought to play a role in cell cycle
regulation. The novel region on chromosome 20 con-
tains two genes: KCNB1 (a voltage-gated potassium
channel gene) and PTGIS. PTGIS (Prostacyclin) is a
particularly interesting candidate because it is a potent
vasodilator and inhibitor of platelet aggregation. In
contrast to these significant findings, the regions with
NRS scores just below the significance threshold (3.0-
4.0) all contained regions with multiple (five or more)
small genes, indicating that such regions may somehow
be inflating the score.
The parameters chosen prior to analyses (window size
300 kb, index threshold of p <0 . 0 0 1 ,a n di n c l u s i o n
threshold of p < 0.01) seem reasonable but are some-
what arbitrary. Using a smaller window size would
increase the likelihood that a region with moderate
p-values clustering in a small area would be more likely
to have a higher NRS score. Requiring an index SNP to
have a smaller p-value, on the other hand, decreases the
number of regions that will be interrogated. This would
increase the possibility that only regions that started off
with a high pointwise rank would have a high NRS score,
while clusters of slightly larger p-values would be
ignored. Making the index parameter more liberal, on
the other hand, would lead to empirical p-values
growing to the point of insignificance. Decisions over
parameters should ultimately be driven by what the
researcher will ultimately trust in the end. For instance, if
a researcher would not trust a region where the
minimum p-value is only 0.01, then the index SNP
threshold should be more stringent.
To test these theories, the algorithm was rerun using
window sizes ranging from 50 kb to 500 kb, as well as
using a more stringent index SNP threshold (p < 0.0001).
The regions on chromosomes 6 and 20 were the only
regions with significant SNPs using the more stringent
index threshold. All four original regions contained
significant SNPs when the window size varied. Only one
n e wr e g i o nw i t hag e n o m e - w i d ep <0 . 0 5w a si d e n t i f i e d
using the smallest window (25 kb on either side of
Figure 1
Histogram of all non-redundant summary (NRS)
scores. The vertical dotted line indicates the empirically
derived genome-wide significance threshold.
Table 1: Statistically significant (genome-wide) regions using 300-kb windows
Chr Region Index SNP Position of
index SNP
No. markers
in region
NRS
score
Empirical
p-value
6 31289808-31589808 rs2523554 31439808 171 8.91 < 0.005
6 32295664-32595664 rs3129941 32445664 119 8.58 < 0.005
9 120670038-120970038 rs7037673 120820038 40 4.96 < 0.01
20 47360021-47660021 rs572845 47510021 67 4.52 < 0.01
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considered significant after correcting for multiple
models. This new region (chromosome 7: 151572154-
151622154) spans a single gene, MLL3,w h i c h ,l i k e
DBC1 on chromosome 9, is associated with a cancer
phenotype.
Even though window size did not have a large impact on
the conclusions reached, future directions will include
modifying the score such that a specific window size
need not be defined explicitly. For example, distance
from the index SNP could be somehow incorporated
into the model. Alternatively, this method could be
adapted to be a gene-based approach, avoiding the issue
altogether. Another future direction is to optimize the
penalty function. Currently, the square root of the
number of markers in the region is employed, since
simply using the number of markers would be too
conservative (because of the redundancy in the data that
we are trying to filter out) and having no penalty at all
would inflate type I error in regions where SNP arrays
have a disproportionate number of SNPs, such as the
HLA region. A more precise correction, perhaps based on
recombination rate or LD distance, will be explored.
Conclusion
The NRS score can be an objective guide to help
researchers prioritize regions for follow up studies.
I n s t a n c e si nw h i c ht h e r ei sc l e a rs e p a r a t i o n( a si st h e
case with Figure 1) can also provide confidence that the
researchers are not wasting valuable time and resources
chasing red herrings.
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